- B cell therapy maker Be Bio stops hemophilia trialBe Biopharma disclosed in a federal clinical trials listing that it has terminated its study of a hemophilia B therapy made by editing a patient’s own cells. It was one of ...Endpoints · 1mo ago↗ source
- FDA raises no major red flags with Moderna's flu shotThe FDA provided tepid support of Moderna’s flu vaccine ahead of an advisory meeting but, more importantly, didn't appear to raise any major concerns that could hinder its prospects. In briefing…Endpoints · 1mo ago↗ source
- FDA greenlights Colorado's drug import proposalThe FDA gave the go-ahead for Colorado to try importing cheaper drugs from Canada, but it remains to be seen how or when this would actually begin. In a letter Monday ...Endpoints · 1mo ago